human genome project
Coverage of human genome project in the Nexus archive.
- When 10,000 doctors stood up and cheered for a cancer drug — America’s innovation machine made it possible
A cancer drug, daraxonrasib, developed by Revolution Medicine, nearly doubled survival rates for pancreatic cancer, sparking a standing ovation at a conference. The article highlights the U.S. innovation model, the 'Innovation Treadmill,' which balances high drug prices with rapid generic substitution to sustain medical breakthroughs. It contrasts U.S. drug access with European delays and discusses trends like genetic advancements and AI in biotech.
- Why a synthetic human genome is still worth building
The article revisits the reasons for constructing a synthetic human genome a decade after the project's launch. It emphasizes the ongoing value of building a human genome from scratch.
- Opinion: Tributes to Craig Venter and the genomics race are missing something important
Craig Venter, a renowned scientist, passed away two weeks ago, leaving behind a legacy of challenging institutional science and its methods. He was a key figure in the genomics race, particularly with his company Celera, which aimed to sequence the human genome before the publicly funded Human Genome Project. Venter's contributions to genomics are still widely recognized.
- Craig Venter of Human Genome Project Dies at 79
Craig Venter, a key figure in the Human Genome Project, has died at 79. He was instrumental in decoding the human genome and advancing genetic research.
- Craig Venter raced to decode the human genome
Craig Venter, a key figure in the Human Genome Project, died on April 29th at the age of 79. He was known for his efforts to decode the human genome.